Human ALOX12B CRISPR Knock Out 293T Cell Line
-
Catalog numberK0076051
-
PricePlease ask
-
Size1x10^6 cells/1.0ml
-
-
Cell line type293T
-
NCBI numberNM_001139
-
AvailabilityPlease contact us every day to check the availability and/or to request a quote. For larger or bulk quantities a discount may apply.
-
OrderingIf you wish to order this product, please include the catalogue number #K0076051in your purchase order among with your shipping and billing information.
-
Technical filePlease contact us to request the latest datasheet, protocol, certificate of analysis and SDS files.
-
NotesDesigned for Research Use Only. Manufactured in Canada.
-
DescriptionFor cells, cell lines and tissues in culture till half confluency.
-
PropertiesHuman proteins, cDNA and human recombinants are used in human reactive ELISA kits and to produce anti-human mono and polyclonal antibodies. Modern humans (Homo sapiens, primarily ssp. Homo sapiens sapiens). Depending on the epitopes used human ELISA kits can be cross reactive to many other species. Mainly analyzed are human serum, plasma, urine, saliva, human cell culture supernatants and biological samples.
-
Gene target
-
Gene symbolALOX12B
-
Short nameALOX12B CRISPR Knock Out Line
-
TechniqueCV40 transformed cell line or 293tsA1609neo from human kidney 293 cells delivered as 1.
-
SpeciesHuman, Humans
-
Alternative nameH. sapiens ALOX12B CRISPR Knock Out 293T cellular Line
-
Tissuecell
-
Gene info
-
Identity
-
Gene
-
Long gene namearachidonate 12-lipoxygenase, 12R type
-
Synonyms
-
Synonyms name
-
GenBank acession
-
Locus
-
Discovery year1998-07-22
-
Entrez gene record
-
Pubmed identfication
-
Classification
- Arachidonate lipoxygenases
-
VEGA ID
-
Locus Specific Databases
MeSH Data
-
Name
-
ConceptScope note: The insertion of recombinant DNA molecules from prokaryotic and/or eukaryotic sources into a replicating vehicle, such as a plasmid or virus vector, and the introduction of the resultant hybrid molecules into recipient cells without altering the viability of those cells.
-
Tree numbers
- E05.393.220
-
Qualifiersdrug effects, methods, radiation effects